Foundation Fighting Blindness Retinal Degeneration Fund is Director of Ocuphire Pharma, Inc.. Currently has a direct ownership of 9.49 Million shares of OCUP, which is worth approximately $9.3 Million. The most recent transaction as insider was on May 05, 2025, when has been sold 6,927,419 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.49M
n/a 3M change
n/a 12M change
Total Value Held $9.3 Million

Foundation Fighting Blindness Retinal Degeneration Fund Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2025
BUY
Conversion of derivative security
-
6,927,419 Added 42.19%
9,492,171 Common Stock
FFB

Foundation Fighting Blindness Retinal Degeneration Fund

Director
Raleigh, NC

Track Institutional and Insider Activities on OCUP

Follow Ocuphire Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUP shares.

Notify only if

Insider Trading

Get notified when an Ocuphire Pharma, Inc. insider buys or sells OCUP shares.

Notify only if

News

Receive news related to Ocuphire Pharma, Inc.

Track Activities on OCUP